8:16 AM
 | 
Jun 08, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Follow-on roundup: ImmunoGen, Mirati, Zymeworks, Viking, OptiNose

ImmunoGen Inc. (NASDAQ:IMGN), Mirati Therapeutics Inc. (NASDAQ:MRTX), Zymeworks Inc. (NYSE:ZYME; TSX:ZYME), Viking Therapeutics Inc. (NASDAQ:VKTX) and OptiNose Inc. (NASDAQ:OPTN) each priced follow-ons, raising a total of more than $465 million.

ImmunoGen raised $150.7 million through the sale of 13.7 million shares at $11 in an upsized follow-on underwritten by J.P. Morgan, Goldman Sachs, Cowen, Canaccord Genuity and H.C. Wainwright. The price is a 4% discount to ImmunoGen's closing price of $11.47 on June 5, when it proposed after hours to sell 12 million shares. The company is conducting the Phase...

Read the full 427 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >